Discovery and Characterization of (8S,9R)‑5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl‑1H‑1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro‑3H‑pyrido[4,3,2-de]phthalazin-3-one (BMN 673, Talazopari... von Wang, Bing, Chu, Daniel, Feng, Ying, Shen, Yuqiao, Aoyagi-Scharber, Mika, Post, Leonard E

Volltext

Restricted Delivery of Talazoparib Across the Blood-Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in Glioblastoma von Kizilbash, Sani H, Gupta, Shiv K, Chang, Kenneth, Kawashima, Ryo, Parrish, Karen E, Carlson, Brett L, Bakken, Katrina K, Mladek, Ann C, Schroeder, Mark A, Decker, Paul A, Kitange, Gaspar J, Shen, Yuqiao, Feng, Ying, Protter, Andrew A, Elmquist, William F, Sarkaria, Jann N

Volltext

Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China von Zhuang, Wei, Fan, Zheng, Chu, Yanqi, Wang, Haizheng, Yang, Ying, Wu, Li, Sun, Nan, Sun, Ge, Shen, Yuqiao, Lin, Xiaolan, Guo, Guiming, Xi, Shengyan

Volltext

Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor von Babcock, Michael C., Mikulka, Christina R., Wang, Bing, Chandriani, Sanjay, Chandra, Sundeep, Xu, Yue, Webster, Katherine, Feng, Ying, Nelvagal, Hemanth R., Giaramita, Alex, Yip, Bryan K., Lo, Melanie, Jiang, Xuntian, Chao, Qi, Woloszynek, Josh C., Shen, Yuqiao, Bhagwat, Shripad, Sands, Mark S., Crawford, Brett E.

Volltext

Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer von Allison Stewart, C, Tong, Pan, Cardnell, Robert J, Sen, Triparna, Li, Lerong, Gay, Carl M, Masrorpour, Fatemah, Fan, You, Bara, Rasha O, Feng, Ying, Ru, Yuanbin, Fujimoto, Junya, Kundu, Samrat T, Post, Leonard E, Yu, Karen, Shen, Yuqiao, Glisson, Bonnie S, Wistuba, Ignacio, Heymach, John V, Gibbons, Don L, Wang, Jing, Byers, Lauren Averett

Volltext

Proteomic Markers of DNA Repair and PI3K Pathway Activation Predict Response to the PARP Inhibitor BMN 673 in Small Cell Lung Cancer von CARDNELL, Robert J, YING FENG, BYERS, Lauren A, LIXIA DIAO, FAN, You-Hong, MASRORPOUR, Fatemah, JING WANG, YUQIAO SHEN, MILLS, Gordon B, MINNA, John D, HEYMACH, John V

Volltext

Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer von Cardnell, Robert J, Feng, Ying, Mukherjee, Seema, Diao, Lixia, Tong, Pan, Stewart, C Allison, Masrorpour, Fatemeh, Fan, YouHong, Nilsson, Monique, Shen, Yuqiao, Heymach, John V, Wang, Jing, Byers, Lauren A

Volltext

Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity von O'Shea, Clodagh C., Johnson, Leisa, Bagus, Bridget, Choi, Serah, Nicholas, Cory, Shen, Annie, Boyle, Larry, Pandey, Kusum, Soria, Conrado, Kunich, John, Shen, Yuqiao, Habets, Gaston, Ginzinger, Dave, McCormick, Frank

Volltext

Trapping Poly(ADP-Ribose) Polymerase von Shen, Yuqiao, Aoyagi-Scharber, Mika, Wang, Bing

Volltext

Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA von ZHANG, Yu-An, NEMUNAITIS, John, SAMUEL, Shirley K, CHEN, Patrick, YUQIAO SHEN, TONG, Alex W

Volltext

BMN 673, a Novel and Highly Potent PARP1/2 Inhibitor for the Treatment of Human Cancers with DNA Repair Deficiency von YUQIAO SHEN, REHMAN, Farah L, YING FENG, BOSHUIZEN, Julia, BAJRAMI, Ilirjana, ELLIOTT, Richard, BING WANG, LORD, Christopher J, POST, Leonard E, ASHWORTH, Alan

Volltext

Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition von Murai, Junko, Feng, Ying, Yu, Guoying K, Ru, Yuanbin, Tang, Sai-Wen, Shen, Yuqiao, Pommier, Yves

Volltext

Human Cytomegalovirus IE1 and IE2 Proteins are Mutagenic and Mediate ``Hit-And-Run" Oncogenic Transformation in Cooperation with the Adenovirus E1A Proteins von Shen, Yuqiao, Zhu, Hua, Shenk, Thomas

Volltext

Red-emitting enhancement of Bi4Si3O12:Sm3+ phosphor by Pr3+ co-doping for White LEDs application von Shen, Yuqiao, Qiu, Kehui, Zhang, Wentao, Zeng, Yu

Volltext

Development of AL01211, a Novel Glucosylceramide Synthase Inhibitor, to Treat Autosomal Dominant Polycystic Kidney Disease (ADPKD): PO1198 von Babcock, Michael C., Zheng, Jianhong, Li, Li, Mei, Changlin, Garovoy, Marvin R., Shen, Yuqiao

Volltext

Analyses of Single-Amino-Acid Substitution Mutants of Adenovirus Type 5 E1B-55K Protein von Shen, Y, Kitzes, G, Nye, J A, Fattaey, A, Hermiston, T

Volltext

Synthesis of Dy3+ co-doped Bi4Si3O12:Sm3+ phosphors with enhanced red-emitting properties von Shen, Yuqiao, Qiu, Kehui, Wang, Junlan, Zhang, Wentao, Tang, Qinxue

Volltext

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral AL01211 in Healthy Chinese Volunteers von Dong, Lei, Xiang, Jianxing, Babcock, Michael, Cheng, Yuanzhi, Wang, Yan, Shen, Yuqiao, Li, Li, Tan, Liping, Garovoy, Marvin, Hu, Wei, Zheng, Jianhong

Volltext

Luminescence enhancement of Ca3Sr3(VO4)4:Eu3+, Sm3+ red-emitting phosphor by charge compensation von Tang, Qinxue, Qiu, Kehui, Zhang, Wentao, Shen, Yuqiao, Wang, Junlan

Volltext

Developing Novel Oncolytic Adenoviruses through Bioselection von Yan, Wen, Kitzes, Galila, Dormishian, Farid, Hawkins, Lynda, Sampson-Johannes, Adam, Watanabe, Josh, Holt, Jenny, Lee, Vivian, Dubensky, Thomas, Fattaey, Ali, Hermiston, Terry, Balmain, Allan, Shen, Yuqiao

Volltext